Evidence has been put forward to suggest that these SOD1 mutant mice have a greater susceptibility to infections and other non-ALS-related conditions, and it has been implied that it is this supplementary illness, rather than ALS, that is alleviated by certain experimental treatments. The gene discussed is SOD1; the disease is infection.